Definium Therapeutics annual total assets
2020
2021
2022
2023
2024
2025
Definium Therapeutics Total Assets Growth & History (DFTX)
Definium Therapeutics's total assets was $440.1M for fiscal 2025.
View full Definium Therapeutics company overviewDefinium Therapeutics annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $440.1M | $137.9M | +45.66% |
| 2024 | 2024-12-31 | $302.2M | $177.6M | +142.61% |
| 2023 | 2023-12-31 | $124.5M | −$45.5M | −26.74% |
| 2022 | 2022-12-31 | $170.0M | $6.0M | +3.65% |
| 2021 | 2021-12-31 | $164.0M | $82.5M | +101.18% |
| 2020 | 2020-12-31 | $81.5M | — | — |
Definium Therapeutics quarterly total assets
Q4.20
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $1.11B | $847.8M | +319.82% |
| Q1 2026 | 2026-03-31 | $401.3M | $126.0M | +45.75% |
| Q4 2025 | 2025-12-31 | $440.1M | $137.9M | +45.66% |
| Q3 2025 | 2025-09-30 | $236.9M | −$82.9M | −25.91% |
| Q2 2025 | 2025-06-30 | $265.1M | −$3.1M | −1.14% |
| Q1 2025 | 2025-03-31 | $275.3M | −$210,000 | −0.08% |
| Q4 2024 | 2024-12-31 | $302.2M | $177.6M | +142.61% |
| Q3 2024 | 2024-09-30 | $319.8M | $178.2M | +125.91% |
| Q2 2024 | 2024-06-30 | $268.1M | $126.1M | +88.72% |
| Q1 2024 | 2024-03-31 | $275.5M | $120.0M | +77.16% |
| Q4 2023 | 2023-12-31 | $124.5M | −$45.5M | −26.74% |
| Q3 2023 | 2023-09-30 | $141.6M | −$39.4M | −21.76% |
| Q2 2023 | 2023-06-30 | $142.1M | $7.8M | +5.81% |
| Q1 2023 | 2023-03-31 | $155.5M | $6.3M | +4.22% |
| Q4 2022 | 2022-12-31 | $170.0M | $6.0M | +3.65% |
| Q3 2022 | 2022-09-30 | $180.9M | — | — |
| Q2 2022 | 2022-06-30 | $134.3M | — | — |
| Q1 2022 | 2022-03-31 | $149.2M | — | — |
| Q4 2021 | 2021-12-31 | $164.0M | $82.5M | +101.18% |
| Q4 2020 | 2020-12-31 | $81.5M | — | — |
Definium Therapeutics total assets trends
Over the last five fiscal years, Definium Therapeutics's total assets increased from $81.5M to $440.1M, a change of $358.6M. The latest reported quarter, Q2 2026, shows $1.11B.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Definium Therapeutics source filings ↗